{"id":"intensive-treatment","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL7257","moleculeType":"Small molecule","molecularWeight":"218.30"},"_dailymed":{"setId":"ca5ab57f-ddcb-4ced-8dd3-a698ad2d17de","title":"PURITO ACNE INTENSIVE TREATMENT (SALICYLIC ACID) PATCH [HINATURE INC.]"},"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By blocking PD-L1, the drug prevents cancer cells from evading immune detection, allowing the immune system to attack and destroy the cancer cells. This mechanism is based on the principle of immune checkpoint inhibition, which has been shown to be effective in treating various types of cancer.","oneSentence":"Inhibits programmed death-ligand 1 (PD-L1) to restore T-cell mediated immune response against cancer cells.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:37:07.246Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06857929","phase":"NA","title":"\"Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition\"","status":"RECRUITING","sponsor":"IMDEA Food","startDate":"2026-03-01","conditions":"Metabolic Syndrome, Obesity Prevention, Obesity and Overweight","enrollment":106},{"nctId":"NCT04284787","phase":"PHASE2","title":"BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-02-16","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Post Cytotoxic Therapy","enrollment":60},{"nctId":"NCT06172296","phase":"PHASE3","title":"Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-04-19","conditions":"Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":478},{"nctId":"NCT04503694","phase":"PHASE2","title":"Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jules Bordet Institute","startDate":"2021-03-25","conditions":"Rectal Cancer Stage II, Rectal Cancer Stage III","enrollment":72},{"nctId":"NCT07413458","phase":"NA","title":"Virtual Reality (VR) NATURE - Alcohol Use Disorder (AUD)","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2026-02-16","conditions":"Alcohol Use Disorder","enrollment":50},{"nctId":"NCT07496749","phase":"NA","title":"KD Treatment for Super-refractory Status Epilepticus","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-10-20","conditions":"Super-refractory Status Epilepticus","enrollment":84},{"nctId":"NCT05386849","phase":"NA","title":"Closed Loop Glucose Control in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Ideal Medical Technologies","startDate":"2022-05-09","conditions":"Diabetes Mellitus, Type 2","enrollment":3},{"nctId":"NCT07431151","phase":"NA","title":"Effects of Intensive Virtual Reality-Based Balance and Gait Training on Activity Performance and Quality of Life in Subacute Stroke Patients","status":"RECRUITING","sponsor":"Ankara Yildirim Beyazıt University","startDate":"2026-02-01","conditions":"Stroke","enrollment":48},{"nctId":"NCT05165810","phase":"NA","title":"Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in India","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-03-09","conditions":"HIV Infections","enrollment":800},{"nctId":"NCT02281097","phase":"NA","title":"Transdermal Vagal Stimulation for POTS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University","startDate":"2013-06","conditions":"Postural Orthostatic Tachycardia Syndrome","enrollment":18},{"nctId":"NCT04530565","phase":"PHASE3","title":"Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-01-25","conditions":"B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1","enrollment":348},{"nctId":"NCT05727930","phase":"NA","title":"Variable Intensive Early Walking Post-Stroke - 2 (VIEWS-2)","status":"RECRUITING","sponsor":"Indiana University","startDate":"2023-01-11","conditions":"Stroke","enrollment":100},{"nctId":"NCT07381023","phase":"NA","title":"Using Breathing Techniques to Ease Anxiety in ICU Patients Awaiting Heart Transplants","status":"NOT_YET_RECRUITING","sponsor":"Hartford HealthCare","startDate":"2026-03","conditions":"Anxiety, Heart Transplant Patients","enrollment":60},{"nctId":"NCT07437950","phase":"PHASE2","title":"Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-10-14","conditions":"Acute Myeloid Leukemia","enrollment":126},{"nctId":"NCT04214249","phase":"PHASE2","title":"BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-02-17","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Post Cytotoxic Therapy","enrollment":49},{"nctId":"NCT07497438","phase":"PHASE3","title":"Comparison of Two Etoposide Initiation Strategies for Severe Hemophagocytic Lymphohistiocytosis","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-04","conditions":"Hemophagocytic Lymphohistiocytosis","enrollment":176},{"nctId":"NCT07498387","phase":"NA","title":"Management of Catatonic Features in Adolescents With Profound Autism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tanta University","startDate":"2026-01-01","conditions":"Autism Spectrum Disorder, Catatonia","enrollment":30},{"nctId":"NCT06743529","phase":"NA","title":"Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2025-11-11","conditions":"Ventilator-Associated Pneumonia (VAP)","enrollment":686},{"nctId":"NCT07037212","phase":"NA","title":"Individualized Medical Nutrition Therapy in Adults With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Serap Balaban Barta","startDate":"2020-12-15","conditions":"Type 2 Diabetes Mellitus (T2DM), Systemic Inflammation, Intestinal Permeability","enrollment":40},{"nctId":"NCT07384585","phase":"NA","title":"Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)","status":"RECRUITING","sponsor":"Laura Beth Kalvas","startDate":"2026-03","conditions":"Circadian Dysregulation, Light Exposure, Pediatric Critical Illness","enrollment":30},{"nctId":"NCT05171257","phase":"","title":"Quantifying Gram-negative Resistance to Empiric Therapy in the Intensive Care Unit","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2021-10-19","conditions":"Gram-Negative Bacterial Infections","enrollment":197},{"nctId":"NCT07096388","phase":"","title":"Evaluation Of Cost-Effectiveness Of Iliac Branch Endoprostheses","status":"NOT_YET_RECRUITING","sponsor":"Prof. Andrea Kahlberg","startDate":"2026-05-01","conditions":"Aorto-iliac Aneurysm","enrollment":300},{"nctId":"NCT07407140","phase":"PHASE3","title":"VAG Versus Standard Chemotherapy With FLT3 Inhibitor in Adult Patients With FLT3-Mutated AML","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-04-30","conditions":"AML, Adult","enrollment":300},{"nctId":"NCT07492030","phase":"","title":"Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2026-03-15","conditions":"Necrotizing Fascitis, Cellulitis, Septic Shock","enrollment":74},{"nctId":"NCT07493759","phase":"","title":"Systemic Immune-Inflamation Index and Mortality in ICU Patients","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2025-12-01","conditions":"Critical Illness, Sepsis","enrollment":570},{"nctId":"NCT06052865","phase":"NA","title":"Serial Brain MRI in Hospitalized Preterm Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2020-09-14","conditions":"Preterm Birth Complication","enrollment":75},{"nctId":"NCT07178366","phase":"NA","title":"Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial)","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2026-05-10","conditions":"Acute-on-Chronic Liver Failure (ACLF)","enrollment":56},{"nctId":"NCT07493096","phase":"","title":"Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders","status":"RECRUITING","sponsor":"Healing Hope International","startDate":"2026-03-01","conditions":"Neurodevelopmental Disorders, Neurodevelopmental Disorders (NDD), Neurodevelopmental Disorders and Developmental Abnormalities","enrollment":100},{"nctId":"NCT05993442","phase":"NA","title":"Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in NICU.","status":"RECRUITING","sponsor":"PENTA Foundation","startDate":"2024-05-28","conditions":"Infection, Bacterial, Infection Prevention","enrollment":3080},{"nctId":"NCT07015424","phase":"NA","title":"Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass","status":"RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2026-03","conditions":"Weight Regain, Weight Loss","enrollment":108},{"nctId":"NCT07492888","phase":"PHASE2","title":"Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS)","status":"NOT_YET_RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2026-04-15","conditions":"Acute Respiratory Distress Syndrome, Severe Community-Acquired Pneum, Sepsis","enrollment":20},{"nctId":"NCT07481253","phase":"NA","title":"PSYCHOPATHY.COMP Program Among Male Prison Inmates With Psychopathy","status":"NOT_YET_RECRUITING","sponsor":"University of Coimbra","startDate":"2026-04-01","conditions":"Antisocial Personality Disorder (ASPD)","enrollment":200},{"nctId":"NCT07490288","phase":"NA","title":"Venetoclax, Azacitidine and Liposomal Mitoxantrone for Newly Diagnosed AML","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"AML","enrollment":30},{"nctId":"NCT06985485","phase":"PHASE2","title":"Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2025-05-17","conditions":"Acute Lymphoblastic Leukemia, Immunotherapy, Blinatumomab","enrollment":26},{"nctId":"NCT07489274","phase":"PHASE4","title":"Adjunctive Hyperbaric Oxygen Treatment for Patients With Necrotizing Soft-Tissue Infection (HOT-NSTI Trial). Investigator-initiated, International, Multicentre, Superiority, Randomized, Open-label, Clinical Trial.","status":"NOT_YET_RECRUITING","sponsor":"Ole Hyldegaard","startDate":"2027-04-01","conditions":"Necrotizing Soft Tissue Infection","enrollment":1480},{"nctId":"NCT06843005","phase":"NA","title":"Serial Coronary CTA-based Plaque Progression Detection for Management of Coronary Heart Disease","status":"RECRUITING","sponsor":"Zhang longjiang,MD","startDate":"2025-02-28","conditions":"Major Adverse Cardiovascular Events (MACE), Prevention, Coronary Artery Disease(CAD)","enrollment":3100},{"nctId":"NCT05722483","phase":"NA","title":"Intensive Virtual Treatment With Remote Abstinence Monitoring for Alcohol Use Disorder","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2023-01-30","conditions":"Alcohol Use Disorder","enrollment":63},{"nctId":"NCT06189924","phase":"","title":"Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients","status":"RECRUITING","sponsor":"The Institute of Molecular and Translational Medicine, Czech Republic","startDate":"2026-03-01","conditions":"Acute Respiratory Failure, Critical Illness","enrollment":200},{"nctId":"NCT07487857","phase":"NA","title":"Intensive Somatosensory Camp for Manual Function and Participation in Children With Unilateral Cerebral Palsy","status":"NOT_YET_RECRUITING","sponsor":"University of Castilla-La Mancha","startDate":"2026-06-20","conditions":"Cerebral Palsy","enrollment":26},{"nctId":"NCT07489092","phase":"NA","title":"Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2026-02-02","conditions":"ICU Acquired Weakness (ICUAW)","enrollment":70},{"nctId":"NCT05713877","phase":"PHASE2","title":"Melatonin for Treatment of Delirium in Critically Ill Adult Patients","status":"RECRUITING","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2023-02-01","conditions":"Delirium","enrollment":30},{"nctId":"NCT07488338","phase":"NA","title":"HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness","status":"RECRUITING","sponsor":"Teachers College, Columbia University","startDate":"2026-03-15","conditions":"Spinal Muscular Atrophy (SMA)","enrollment":20},{"nctId":"NCT04700202","phase":"","title":"Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2020-06-30","conditions":"Ventilator-associated Pneumonia, Hospital-acquired Pneumonia","enrollment":132},{"nctId":"NCT06505447","phase":"NA","title":"PICU-related Sleep and Circadian Dysregulation Pilot Study","status":"RECRUITING","sponsor":"State University of New York at Buffalo","startDate":"2024-12-06","conditions":"Circadian Dysrhythmia, Sleep Disturbance, Critical Illness","enrollment":30},{"nctId":"NCT06225167","phase":"","title":"Pharmacist-Driven Stress Ulcer Prophylaxis Minimization in the Intensive Care Unit","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2023-05-13","conditions":"Stress Ulcer","enrollment":120},{"nctId":"NCT05996835","phase":"PHASE2","title":"Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-01-18","conditions":"Acute Kidney Injury Due to Sepsis","enrollment":320},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT07486726","phase":"PHASE1, PHASE2","title":"Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2026-03-15","conditions":"Acute Myeloid Leukemia (AML), Relapse Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia (AML)","enrollment":112},{"nctId":"NCT06990451","phase":"NA","title":"Time Pressure Motor Training With Step Square Exercise on Stroke Patients","status":"COMPLETED","sponsor":"October 6 University","startDate":"2025-06-01","conditions":"Stroke","enrollment":38},{"nctId":"NCT06852222","phase":"PHASE3","title":"A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2025-06-04","conditions":"Leukemia, Myeloid, Acute","enrollment":600},{"nctId":"NCT07254299","phase":"NA","title":"Hypnosis to Improve Well-beings of Critically Ill Patients and Prevent Post-intensive Care Syndrome","status":"NOT_YET_RECRUITING","sponsor":"COEN Matteo","startDate":"2026-03-01","conditions":"Post Intensive Care Syndrome (PICS)","enrollment":150},{"nctId":"NCT07481682","phase":"NA","title":"Impact of Inhaled Tranexamic Acid in Pulmonary Hemorrhage in Pediatric Intensive Care Unit","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-08-01","conditions":"Tranexamic Acid, Pulmonary Hemorrhage, Pediatric","enrollment":100},{"nctId":"NCT06994715","phase":"NA","title":"Effects of Acupressure Applied to Intensive Care Patients on Physiological Parameters, Pain, Sleep Quality, Anxiety and Perception of Nursing Presence","status":"COMPLETED","sponsor":"Gazi University","startDate":"2025-05-01","conditions":"Acupressure, Intensive Care Unit, Anxiety","enrollment":60},{"nctId":"NCT06667999","phase":"PHASE4","title":"The Intensive Care Platform Trial","status":"RECRUITING","sponsor":"Anders Perner","startDate":"2025-06-26","conditions":"Intensive Care Patients, Intensive Care Unit Patients, Critical Illness","enrollment":10000},{"nctId":"NCT06517251","phase":"NA","title":"Aha BOOST Arm-hand BOOST Therapy to Enhance Recovery After Stroke: Clinical, Health Economic and Process Evaluation","status":"RECRUITING","sponsor":"KU Leuven","startDate":"2024-06-17","conditions":"Stroke","enrollment":80},{"nctId":"NCT05035056","phase":"","title":"WARRIOR Ancillary Study for CCTA Analysis","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2020-07-01","conditions":"Coronary Artery Disease, Non-Obstructive Coronary Atherosclerosis, Ischemia","enrollment":191},{"nctId":"NCT06870812","phase":"NA","title":"Rapid Evacuation and Access of Cerebral Hemorrhage Trial","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-05-27","conditions":"Stroke Hemorrhagic","enrollment":600},{"nctId":"NCT07481773","phase":"NA","title":"Biomarker Signature-Supported Antibiotic Treatment Decisions in ICU","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2025-05-13","conditions":"Intensive Care Unit (ICU) Admission","enrollment":1200},{"nctId":"NCT05681260","phase":"PHASE3","title":"Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)","status":"RECRUITING","sponsor":"Children's Cancer Group, China","startDate":"2023-02-06","conditions":"T-cell Lymphoblastic Lymphoma","enrollment":200},{"nctId":"NCT06795893","phase":"","title":"The Anifrolumab PRIM Program","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-11-07","conditions":"Systemic Lupus Erythematosus","enrollment":240},{"nctId":"NCT06499701","phase":"","title":"Volume Kinetics of Fluid Resuscitation in Early Sepsis","status":"RECRUITING","sponsor":"Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu","startDate":"2024-06-19","conditions":"Fluid and Electrolyte Imbalance","enrollment":15},{"nctId":"NCT04855370","phase":"NA","title":"Non-Invasive Measurement of Cardiac Output and Stroke Volume in PE","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2025-07-15","conditions":"Pulmonary Embolism, Pulmonary Embolus/Emboli, Pulmonary Disease","enrollment":""},{"nctId":"NCT07102875","phase":"NA","title":"Ready to Sail 2: A Pilot Study of Sail-Assisted Telerehabilitation in Rare Skeletal Diseases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2025-07-15","conditions":"Rare Bone Disorders","enrollment":24},{"nctId":"NCT04989790","phase":"NA","title":"Clinical Effectiveness of the \"PICU Up!\" Multifaceted Early Mobility Intervention for Critically Ill Children","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-08-08","conditions":"Child, Intensive Care Unit Acquired Weakness, Critical Illness","enrollment":1440},{"nctId":"NCT05803343","phase":"NA","title":"Evaluating Additive Effects of Including Canines in Regulating Together","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2023-02-28","conditions":"Autism Spectrum Disorder, Emotion Regulation","enrollment":240},{"nctId":"NCT04119544","phase":"NA","title":"Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2)","status":"RECRUITING","sponsor":"Clinique Les Trois Soleils","startDate":"2019-12-10","conditions":"Stroke","enrollment":66},{"nctId":"NCT02129244","phase":"NA","title":"A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2014-10","conditions":"MDR-TB, HIV","enrollment":3600},{"nctId":"NCT07037784","phase":"NA","title":"Monitoring of Patient Physiological Parameters in Real Life Using OXYFLEX® Biosensors Versus Standard Monitoring","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2026-05","conditions":"Physiological Parameters","enrollment":102},{"nctId":"NCT02845882","phase":"PHASE3","title":"LBL-2016 for Children or Adolescents in China","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Cancer Group, China","startDate":"2016-01","conditions":"Lymphoblastic Lymphoma","enrollment":150},{"nctId":"NCT05803369","phase":"NA","title":"DOD Regulating Together Intervention","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2022-08-01","conditions":"Autism Spectrum Disorder, Emotion Regulation","enrollment":144},{"nctId":"NCT07465354","phase":"NA","title":"OCD Summer Treatment Program for Adolescents in Iceland","status":"NOT_YET_RECRUITING","sponsor":"University of Iceland","startDate":"2026-05-01","conditions":"Obsessive-Compulsive Disorder (OCD)","enrollment":70},{"nctId":"NCT06446739","phase":"NA","title":"LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM)","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2024-11-14","conditions":"Acute Kidney Injury, Dialysis; Complications","enrollment":100},{"nctId":"NCT04695119","phase":"","title":"Sepsis in the ICU-II","status":"ACTIVE_NOT_RECRUITING","sponsor":"Linkoeping University","startDate":"2018-09-17","conditions":"Septic Shock, Sepsis, Cardiomyopathies","enrollment":379},{"nctId":"NCT07478458","phase":"NA","title":"ADRIS Driving Simulator for Adolescents With Attention Deficit and Hyperactivity Disorder","status":"RECRUITING","sponsor":"Istituto Giannina Gaslini","startDate":"2025-11-10","conditions":"ADHD - Attention Deficit Disorder With Hyperactivity","enrollment":120},{"nctId":"NCT07474064","phase":"PHASE2","title":"Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC","status":"NOT_YET_RECRUITING","sponsor":"chenxu","startDate":"2026-03-26","conditions":"Muscle Invasive Bladder Cancer (MIBC)","enrollment":146},{"nctId":"NCT07167940","phase":"PHASE3","title":"Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-07-01","conditions":"PTSD","enrollment":90},{"nctId":"NCT07472660","phase":"NA","title":"Intensive Prevention Program After Decompensated Heart Failure","status":"RECRUITING","sponsor":"Herzzentrum Bremen","startDate":"2025-10-01","conditions":"Heart Failure","enrollment":200},{"nctId":"NCT07475767","phase":"","title":"Ultrasound Indicators of Nutritional Status and Treatment Outcomes in Surgical Patients in the Intensive Care Unit","status":"RECRUITING","sponsor":"Osijek University Hospital","startDate":"2026-02-01","conditions":"Nutritional Status, Muscle Thickness of the Quadriceps Femoris, Frailty","enrollment":50},{"nctId":"NCT07472452","phase":"","title":"MULTIMODAL APPROACH IN THE DIAGNOSIS OF SEPTIC AKI","status":"NOT_YET_RECRUITING","sponsor":"Ankara Etlik City Hospital","startDate":"2026-03-30","conditions":"Acute Kidney Injury, Sepsis, Critical Illness","enrollment":130},{"nctId":"NCT07472374","phase":"PHASE3","title":"Functional Restoration for Chronic Low Back Pain: Medico-economic Impact","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03-10","conditions":"Nonspecific Chronic Low Back Pain With Work Disability","enrollment":242},{"nctId":"NCT06809348","phase":"NA","title":"Development of PRECISE: A Data Driven Personalized Suicide Prevention Intervention","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2025-11-14","conditions":"Suicidal Thoughts and Behaviors","enrollment":70},{"nctId":"NCT07223320","phase":"NA","title":"HABIT-ILE + FST in Children With SMA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Teachers College, Columbia University","startDate":"2025-10-01","conditions":"SMA - Spinal Muscular Atrophy","enrollment":5},{"nctId":"NCT04961580","phase":"","title":"PK/PD of Ceftazidime Avitbatan Sodium in Children With Severe Infection","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2022-10-01","conditions":"Sepsis, Antibiotic Reaction","enrollment":30},{"nctId":"NCT07475650","phase":"NA","title":"Virtual Reality in ICU Patients With COPD","status":"COMPLETED","sponsor":"TC Erciyes University","startDate":"2022-11-29","conditions":"COPD, Sleep Quality of ICU Patients, Anxiety","enrollment":50},{"nctId":"NCT07372924","phase":"PHASE2","title":"A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Care Unit (ICU)","status":"RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2026-02-24","conditions":"Abirritation in the ICU","enrollment":120},{"nctId":"NCT04353804","phase":"NA","title":"Returning to Everyday Tasks Utilizing Rehabilitation Networks-III (RETURN-III)","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2022-10-03","conditions":"Cognitive Rehabilitation, ICU Survivorship, Intensive Care Unit","enrollment":160},{"nctId":"NCT07469072","phase":"PHASE2","title":"Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU)","status":"NOT_YET_RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2026-02-25","conditions":"Continuous Renal Replacement Therapy (CRRT)","enrollment":92},{"nctId":"NCT07007312","phase":"PHASE3","title":"Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML","status":"RECRUITING","sponsor":"Kura Oncology, Inc.","startDate":"2025-09-26","conditions":"Acute Myeloid Leukemia (AML)","enrollment":1300},{"nctId":"NCT07471321","phase":"NA","title":"Parental EMDR Therapy After a Baby's Stay in the NICU","status":"NOT_YET_RECRUITING","sponsor":"Kuopio University Hospital","startDate":"2026-03","conditions":"Stress Disorders, Post-Traumatic","enrollment":80},{"nctId":"NCT06930352","phase":"PHASE2","title":"Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy","status":"NOT_YET_RECRUITING","sponsor":"Uma Borate","startDate":"2026-04-10","conditions":"Acute Myeloid Leukemia","enrollment":70},{"nctId":"NCT05735184","phase":"PHASE1","title":"A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML","status":"RECRUITING","sponsor":"Kura Oncology, Inc.","startDate":"2023-07-18","conditions":"Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation, Refractory AML","enrollment":420},{"nctId":"NCT07469696","phase":"NA","title":"The Effect of Robot-assisted Walking Training on Motor Functions, Respiratory Parameters and Functional Capacity in Cerebral Palsy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Istanbul University - Cerrahpasa","startDate":"2024-12-20","conditions":"Cerebral Palsy (CP)","enrollment":24},{"nctId":"NCT07466277","phase":"NA","title":"Intermittent Theta Burst Stimulation of the Prefrontal Cortex in Social Anxiety Disorder","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-12-09","conditions":"Social Anxiety Disorder (SAD)","enrollment":100},{"nctId":"NCT07467252","phase":"PHASE2","title":"AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCT","status":"NOT_YET_RECRUITING","sponsor":"Ministry of Health, Saudi Arabia","startDate":"2026-09","conditions":"Pulmonary Tuberculosis","enrollment":200},{"nctId":"NCT07262320","phase":"","title":"Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-03-01","conditions":"Dialysis, Critically Ill Acute Kidney Injury, Renal Replacement Therapy for Acute Kidney Injury in ICU","enrollment":1000},{"nctId":"NCT04746235","phase":"PHASE2","title":"Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-22","conditions":"Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia","enrollment":85},{"nctId":"NCT07390786","phase":"NA","title":"Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2026-01-30","conditions":"Critical Illness Recovery, Behavioral Health Concerns, Anxiety","enrollment":150},{"nctId":"NCT07465250","phase":"NA","title":"Effects of Combined Blue and Red Home-Based Light Therapy on Sleep in Adults With Self-Reported Sleep Difficulties","status":"COMPLETED","sponsor":"Colorado State University","startDate":"2024-07-09","conditions":"Sleep","enrollment":20},{"nctId":"NCT05453903","phase":"PHASE1","title":"A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-10-04","conditions":"Leukemia, Myeloid, Acute","enrollment":196},{"nctId":"NCT07268417","phase":"","title":"Group Medical Appointments for Intensive Lifestyle Treatment for Obesity in Cleveland Clinic Primary Care Practices","status":"ENROLLING_BY_INVITATION","sponsor":"Anita Misra-Hebert","startDate":"2024-12-01","conditions":"Obesity & Overweight","enrollment":3600}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Poor response to previous biologic therapy"],"phase":"marketed","status":"active","brandName":"Intensive treatment","genericName":"Intensive treatment","companyName":"Innovent Biologics (Suzhou) Co. Ltd.","companyId":"innovent-biologics-suzhou-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Intensive treatment involves interventions such as regular insulin and exercise, which are studied in conditions including acute coronary syndrome and Parkinson disease. The modality of intensive treatment is a small molecule, although the specific compound is not specified in the provided information.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}